Why the study?
Cardiac autonomic neuropathy represents a serious complication of diabetic neuropathies, but its presence required investigation among adult diabetic Sudanese patients with ischemic heart disease.
Cardiovascular autonomic neuropathy is highly prevalent among diabetic patients presenting with acute coronary syndrome, highlighting the potential utility of early autonomic function testing.
May support CAN screening in diabetic IHD patients; leaves open prognostic value and need for prospective outcome trials.
Introduction : Diabetic neuropathies are thought to result from diabetic microvascular injury involving small blood vessels that supply nerves. Cardiac autonomic neuropathy (CAN) represents a serious complication associated with Diabetic neuropathies. Objectives : The aim of the study is to investigate the presence of cardiovascular diabetic autonomic neuropathy in a group of adult diabetic Sudanese patients with ischemic heart disease. Methodology : This is a descriptive prospective cross sectional hospital based study. The study population included type 1 and type 2 diabetic patients admitted to the cardiac care unit in ELshaab Teaching Hospital with acute coronary syndrome over a period of two years, from April 2017to April 2019. Results : A total of 49 males (65.33%) and 26 females (34.67%) were included in the study. CAN was detected in 94.67% of the studied group Conclusion : An incidence of 94.67% cardiovascular autonomic neuropathy in our sample indicates a high occurrence of this syndrome among our diabetic patients. Poor glycemic control is a common feature among our studied group. Sub-clinical autonomic neuropathy can be detected early using autonomic function tests.
No takes yet. Share an insight, caveat, or question.
Siddig et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: